Monsanto-Bayer Deal One Step Closer to Completion After Bayer Agrees to Asset Sale Deal With BASF
Bayer agreed to sell select crop science businesses to BASF for EUR 5.9 billion in a deal that is likely to satisfy regulator’s concerns regarding Bayer’s proposed acquisition of Monsanto. The crop science businesses that Bayer will divest include a portion of the LibertyLink genetically modified (GM) platform as well as some seeds and crop chemicals assets. Since the acquisition was announced in September 2016, we have expected Bayer would need to divest some seeds assets as a condition to gain...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.